World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
47449
World Ranking
4951
National Ranking
17

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Dario Campana is affiliated with the National University of Singapore in Singapore. Their primary field of study is Medicine, with a focus on several subfields including Oncology, Public Health, Environmental and Occupational Health, Immunology, Pediatrics, Perinatology and Child Health, and Molecular Biology.

The scientist's research topics cover a range of areas, prominently featuring:

  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Immune Cell Function and Interaction
  • Childhood Cancer Survivors' Quality of Life
  • Viral Infectious Diseases and Gene Expression in Insects
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment

Among recent publications by Dario Campana are:

  • "NK cells for cancer immunotherapy" (2020), published in Nature Reviews Drug Discovery
  • "Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease-Directed Therapy" (2021), published in Blood Cancer Discovery
  • "Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers" (2020), published in Clinical Cancer Research
  • "Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study" (2020), published in Blood
  • "Fratricide-resistant CD7-CAR T cells in T-ALL" (2024), published in Nature Medicine

Their most frequent co-authors include:

  • Elaine Coustan-Smith
  • Noriko Shimasaki
  • Cheng Cheng
  • Sima Jeha
  • John Choi

Regarding publication venues, Dario Campana has published notably in:

  • Blood
  • Clinical Cancer Research
  • Blood Advances
  • Nature Reviews Drug Discovery
  • Blood Cancer Discovery

Dario Campana has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

    Eng Juh Yeoh;Mary E. Ross;Sheila A. Shurtleff;W. Kent Williams

  • The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

    Jinghui Zhang;Li Ding;Linda Holmfeldt;Gang Wu

  • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

    Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke

  • Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

    Michael C. Milone;Jonathan D. Fish;Jonathan D. Fish;Carmine Carpenito;Richard G. Carroll

  • Treating childhood acute lymphoblastic leukemia without cranial irradiation.

    Ching Hon Pui;Dario Campana;Deqing Pei;W. Paul Bowman

  • Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Charles G. Mullighan;Mihaela Onciu;Frederick G. Behm

  • Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia

    C. Imai;K. Mihara;M. Andreansky;I. C. Nicholson

  • Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

    Chihaya Imai;Shotaro Iwamoto;Shotaro Iwamoto;Dario Campana;Dario Campana

  • Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy

    Hiroyuki Fujisaki;Harumi Kakuda;Noriko Shimasaki;Chihaya Imai

  • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;James M. Boyett

  • Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Frederick G. Behm;Frederick G. Behm;Joaquin Sanchez;James M. Boyett;James M. Boyett

  • Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance

    D. Campana;Ching-Hon Pui

  • Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

    Jeffrey E. Rubnitz;Hiroto Inaba;Gary Dahl;Raul C. Ribeiro

  • Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

    Ching Hon Pui;John T. Sandlund;Deqing Pei;Dario Campana

  • Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.

    Malek Faham;Jianbiao Zheng;Martin Moorhead;Victoria E. H. Carlton

  • Primary B Cell Immunodeficiencies: Comparisons and Contrasts

    Mary Ellen Conley;A Kerry Dobbs;Dana M Farmer;Sebnem Kilic

  • An essential role for BLNK in human B cell development.

    Yoshiyuki Minegishi;Jurg Rohrer;Elaine Coustan-Smith;Howard M. Lederman

  • Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

    Shotaro Iwamoto;Keichiro Mihara;James R. Downing;Ching-Hon Pui

  • A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells

    Yu-Hsiang Chang;John Connolly;Noriko Shimasaki;Kousaku Mimura

  • Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.

    M Buschle;D Campana;S R Carding;C Richard

Frequent Co-Authors

Elaine Coustan-Smith
Elaine Coustan-Smith National University of Singapore
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Jeffrey E. Rubnitz
Jeffrey E. Rubnitz St. Jude Children's Research Hospital
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
James R. Downing
James R. Downing St. Jude Children's Research Hospital
William E. Evans
William E. Evans St. Jude Children's Research Hospital
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital
John T. Sandlund
John T. Sandlund National Institutes of Health
Frederick G. Behm
Frederick G. Behm University of Illinois at Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open doors to many online degree options and alternative career pathways in healthcare. For registered nurses looking to advance, exploring rn to bsn without clinicals offers a flexible way to earn a bachelor’s degree with little or no in-person clinical experience required, ideal for working professionals.

For those already holding a master’s in nursing, accelerated msn to dnp programs provide a faster route to a terminal degree, enhancing leadership opportunities. Alternatively, some may prefer online dnp programs without clinicals, offering maximum flexibility and a less intensive clinical load.

If you are at the beginning of your nursing journey, online lpn programs can be a cost-effective and fast-paced way to enter the workforce. These online pathways allow students to balance studies with work and family, making medical careers more accessible than ever before.

Best Scientists Citing Dario Campana

Trending Scientists

Recently Published Articles